Skip to content

Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504460-41-00
Acronym
AGMB-129-C103
Enrollment
24
Registered
2023-07-25
Start date
2024-01-30
Completion date
2024-05-13
Last updated
2024-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrostenotic Crohn’s disease

Interventions

None listed

Sponsors

Agomab Spain S.L.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026